Fact CheckerSign in

NCT07047573Recruiting

Multi-omics Detection Techniques for Differentiating Benign and Malignant Pulmonary Nodules

Clinical Application Research on Differentiating Benign and Malignant Pulmonary Nodules Based on Multi-omics Detection Technology

Source: ClinicalTrials.gov · Last updated 2 Jul 2025 · Not updated for over 12 months - ask the site whether it is still open

Brief summary (registry, in English)

Research objective: To explore the clinical application effect of multi-omics detection based on flow cytometry analysis, single-cell data and images combined with clinical features in differentiating the benign and malignant nature of pulmonary nodules and the early diagnosis of lung cancer

Status (registry)
Recruiting
Study type
Observational
Enrollment
150 (estimated)
First submitted
24 Jun 2025
Start date
1 Jun 2025
Primary completion date
30 Jun 2026
Lead sponsor
Zhao Jun
NCT number
NCT07047573

What you commit to

  • Study type: Observational
  • Planned participants: 150
  • From 1 Jun 2025 to the primary completion date, 30 Jun 2026
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Refuse surgical treatment
  • Abnormal coagulation function or receiving anticoagulant or thrombolytic therapy.

Other illness

  • Patients with hematogenic infectious diseases, such as HIV, hepatitis B or hepatitis C.
  • Poor vascular conditions.
  • Patients with hematogenic infectious diseases, such as HBV.
  • Patients with psychiatric disorders or severe mental illnesses.

Other

  • Patient has no ct examination results
  • Patient has no clear pathological diagnosis
  • Patients with tumor emergencies that require immediate treatment.
  • Patients who have difficulty communicating or are unable to be followed up for a long time

Who the study is looking for

  • Patient underwent a ct examination
  • Patient was confirmed to have pulmonary nodules
  • Patient has been determined to undergo surgical treatment
  • There are clear pathological results
  • The clinicopathological data are complete

Sex: All · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Soochow university
Coordinator of this site? Confirm its status
SuzhouChinaRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.